VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

10897	Companies
237410	Keywords
166346	Articles
127498	Press releases

Home
Companies
VALNEVA

BRIEF

published on 08/19/2026 at 15:50, 9 days 17 hours ago

Valneva SE's Q2 Sales Decline Amid New Projections

Valneva SE Q2 Sales Decline Ixiaro Contract Gross Margin Rebound LB6V Vaccine Approval
PRESS RELEASE

published on 08/19/2026 at 15:45, 9 days 17 hours ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates research on Valneva SE, maintaining Buy rating and lowering target price from €4.50 to €4.40 following Q2 results, projecting rebound in gross margin and likelihood of FDA approval for Lyme disease vaccine candidate LB6V

BUY Rating Research Update Target Price Q2 Results Valneva SE
BRIEF

published on 08/14/2026 at 07:05, 15 days 2 hours ago

EMA Validates Marketing Application for Lyme Disease Vaccine by Pfizer and Valneva

Valneva Lyme Disease Vaccine Candidate Pfizer EMA Validation
PRESS RELEASE

published on 08/14/2026 at 07:00, 15 days 2 hours ago

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
European Medicines Agency validates Pfizer and Valneva's MAA for Lyme Disease Vaccine Candidate based on Phase 3 results. Potential game-changer in Lyme disease prevention

Valneva Lyme Disease Vaccine Pfizer European Medicines Agency Phase 3 VALOR Trial
PRESS RELEASE

published on 08/13/2026 at 07:00, 16 days 2 hours ago

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates
Valneva SE reports half-year 2026 financial results, maintains full-year guidance, strengthens cash position, and provides corporate updates. Live webcast of results conference call available

Financial Results Revenue Valneva SE Half-year Corporate Updates
BRIEF

published on 07/22/2026 at 17:50, 1 month 6 days ago

Valneva to Announce First Half 2026 Financial Results

Financial Results Forward-looking Statements Webcast Vaccine Development Market Approvals
PRESS RELEASE

published on 07/22/2026 at 17:45, 1 month 6 days ago

Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
Valneva SE to report First Half 2026 Consolidated Financial Results on August 13, 2026. The live webcast will discuss financial results and provide a business update

Financial Results Business Update Valneva SE Live Webcast Vaccine Company
BRIEF

published on 06/25/2026 at 17:50, 2 months 3 days ago

Valneva Confirms Leadership Changes at Annual General Meeting

Annual General Meeting Leadership Change Valneva SE Shareholder Resolutions Biopharmaceutical Governance
PRESS RELEASE

published on 06/25/2026 at 17:45, 2 months 3 days ago

Valneva Announces Successful Outcome of its Annual General Meeting
Valneva SE announces successful outcome of its Annual General Meeting in Lyon, France. Dr. Gerd Zettlmeissl appointed as Chair of the Board of Directors. Key resolutions passed

Board Of Directors Annual General Meeting Lyon Valneva SE Dr. Gerd Zettlmeissl
BRIEF

published on 05/18/2026 at 17:24, 3 months 10 days ago

Valneva SE Maintains Buy Rating Despite Sales Decline

FDA Approval BUY Rating Valneva SE Lyme Vaccine Q1 2026 Results

Accesswire

Published on 08/29/2026 at 05:15, 3 hours 51 minutes ago

Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 5 hours 46 minutes ago

BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 7 hours 51 minutes ago

Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Published on 08/29/2026 at 01:00, 8 hours 6 minutes ago

Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Published on 08/28/2026 at 23:00, 10 hours 6 minutes ago

Guanajuato Silver Grants Stock Options to Officer

View all ACCESSWIRE

EQS Group

Published on 08/29/2026 at 04:05, 5 hours 1 minute ago

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
Published on 08/28/2026 at 20:49, 12 hours 16 minutes ago

Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/28/2026 at 20:42, 12 hours 24 minutes ago

Aroundtown SA: Release of a capital market information
Published on 08/28/2026 at 19:10, 13 hours 55 minutes ago

Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 15 hours 4 minutes ago

CPI Europe announces unaudited results for the first half of 2026

Les Echos

Published on 08/28/2026 at 06:55, 1 day 2 hours ago

Recticel Accelerates Profitable Growth
Published on 08/26/2026 at 18:02, 2 days 15 hours ago

Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 2 days 15 hours ago

Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 17:40, 2 days 15 hours ago

First half 2026 results
Published on 08/25/2026 at 17:45, 3 days 15 hours ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE